Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
11.13
+0.15 (1.37%)
Dec 26, 2025, 2:56 PM EST
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $279.75 million as of December 26, 2025. Its market cap has increased by 3.77% in one year.
Market Cap
279.75M
Enterprise Value
284.81M
Revenue
50.06M
Ranking
n/a
PE Ratio
16.11
Stock Price
$11.13
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 279.75M, an increase of 382.37%. That is a compound annual growth rate of 7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 279.75M | 9.84% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | 19.73M | -36.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |